C-reactive protein level in late-onset depression: A case-control study
- PMID: 30581212
- PMCID: PMC6278212
- DOI: 10.4103/psychiatry.IndianJPsychiatry_127_17
C-reactive protein level in late-onset depression: A case-control study
Abstract
Background: Late-onset depression (LOD) is less responsive to standard antidepressant medication compared to early-onset depressive disorder. A group of early-onset depressive episode is less responsive to antidepressant medication, and immune dysregulation is critically involved in it. LOD has been associated with increased vascular risk factor and atherosclerosis and immune dysregulation is critically involved in vascular disease. We hypothesized that increased inflammatory activity may be associated with late-onset depressive disorders.
Aim: The aim of this study is to study the C-reactive protein (CRP) levels in LOD compared with age-matched controls and association between CRP levels and severity of depressive episode.
Settings and design: This was a case-control study at tertiary care psychiatry department.
Materials and methods: Depressed patients (as per International Classification of Disease 10 Diagnostic and Research Criteria) of age >55 years were recruited and age-matched control participant were recruited after informed consent. A complete clinical assessment, assessment of vascular risk factors, blood sample for the evaluation of serum CRP was obtained, and baseline depression severity was measured on Hamilton Depression Rating Scale (HDRS).
Statistical analysis: The quantitative and qualitative variables were described as means, standard deviation, and P value. The student's t-test for parametric data and the mann-whitney test for nonparametric data spearman correlation coefficient method were used.
Results: The mean age of cases (n = 25) was 64.7 ± 5.8 years, and mean age of controls (n = 25) was 64.2 ± 3.7 years. Patients with current depressive disorders had 40% times higher levels of CRP than control. Baseline HDRS of cases was 18 ± 3. CRP level and depression severity shows strong positive (r = 0.935, P = <0.001) correlation between CRP level and depression severity.
Conclusion: LOD was associated with higher level of CRP compared to age-matched nondepressed patients. Raised CRP was associated with severity of depressive episode of LOD.
Keywords: C-reactive protein; Case–control study; immune dysregulation in late-onset depression; late-onset depression.
Conflict of interest statement
There are no conflicts of interest.
Similar articles
-
Baseline serum C-reactive protein levels may predict antidepressant treatment responses in patients with major depressive disorder.J Affect Disord. 2019 May 1;250:432-438. doi: 10.1016/j.jad.2019.03.001. Epub 2019 Mar 4. J Affect Disord. 2019. PMID: 30878656
-
Association of depressive disorders, depression characteristics and antidepressant medication with inflammation.Transl Psychiatry. 2012 Feb 21;2(2):e79. doi: 10.1038/tp.2012.8. Transl Psychiatry. 2012. PMID: 22832816 Free PMC article.
-
C-reactive protein and cortisol in drug-naïve patients with short-illness-duration first episode major depressive disorder: possible role of cortisol immunomodulatory action at early stage of the disease.J Affect Disord. 2014 Jan;152-154:534-7. doi: 10.1016/j.jad.2013.10.004. Epub 2013 Oct 10. J Affect Disord. 2014. PMID: 24161452
-
ECNP consensus meeting. Bipolar depression. Nice, March 2007.Eur Neuropsychopharmacol. 2008 Jul;18(7):535-49. doi: 10.1016/j.euroneuro.2008.03.003. Epub 2008 May 23. Eur Neuropsychopharmacol. 2008. PMID: 18501566 Review.
-
Novel Augmentation Strategies in Major Depression.Dan Med J. 2017 Apr;64(4):B5338. Dan Med J. 2017. PMID: 28385173 Review.
Cited by
-
Metabolomics Based on Peripheral Blood Mononuclear Cells to Dissect the Mechanisms of Chaigui Granules for Treating Depression.ACS Omega. 2022 Mar 7;7(10):8466-8482. doi: 10.1021/acsomega.1c06046. eCollection 2022 Mar 15. ACS Omega. 2022. PMID: 35309492 Free PMC article.
-
Precision Psychiatry: Biomarker-Guided Tailored Therapy for Effective Treatment and Prevention in Major Depression.Adv Exp Med Biol. 2021;1305:535-563. doi: 10.1007/978-981-33-6044-0_27. Adv Exp Med Biol. 2021. PMID: 33834417 Review.
-
Identification of key genes in late-onset major depressive disorder through a co-expression network module.Front Genet. 2022 Dec 6;13:1048761. doi: 10.3389/fgene.2022.1048761. eCollection 2022. Front Genet. 2022. PMID: 36561317 Free PMC article.
-
C-Reactive Protein as a Biomarker for Major Depressive Disorder?Int J Mol Sci. 2022 Jan 30;23(3):1616. doi: 10.3390/ijms23031616. Int J Mol Sci. 2022. PMID: 35163538 Free PMC article. Review.
-
Evaluation of inflammatory cytokines in drug-naïve major depressive disorder: A systematic review and meta-analysis.Int J Immunopathol Pharmacol. 2023 Jan-Dec;37:3946320231198828. doi: 10.1177/03946320231198828. Int J Immunopathol Pharmacol. 2023. PMID: 37625799 Free PMC article.
References
-
- Demyttenaere K, Bruffaerts R, Posada-Villa J, Gasquet I, Kovess V, Lepine JP, et al. Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization world mental health surveys. JAMA. 2004;291:2581–90. - PubMed
-
- Blazer DG. Depression in late life: Review and commentary. J Gerontol A Biol Sci Med Sci. 2003;58:249–65. - PubMed
-
- Hamer M, Bates CJ, Mishra GD. Depression, physical function, and risk of mortality: National diet and nutrition survey in adults older than 65 years. Am J Geriatr Psychiatry. 2011;19:72–8. - PubMed
-
- Schweitzer I, Tuckwell V, O’Brien J, Ames D. Is late onset depression a prodrome to dementia? Int J Geriatr Psychiatry. 2002;17:997–1005. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous